Almac expands cold storage by 400%; New Gerresheimer chief aims for global growth;

> CMO Almac is betting on a surge in demand for cold storage as the pharmaceutical industry shifts focus towards temperature-sensitive biologics, boosting its capacity by 400 percent. Report

> New Gerresheimer CEO Uwe Roehrhoff wants the German firm to become the pharmaceutical and biopharmaceutical industry's "first choice" partner for high-tech packaging. Report

> India's Surya Pharmaceutical said it has started commercial production at its Jammu plant, which has the capacity to manufacture APIs and sterile products per U.S. FDA norms. Report

> Schott Pharmaceutical Packaging has boosted its U.S.-based ready-to-fill (RTF) syringe production line capabilities, counting on U.S. demand to grow by 10 percent per year. Report

> Indian Immunologicals, a subsidiary of National Dairy Development Board and the largest veterinary biological company in India, is setting up a new project for production of human and veterinary vaccines and veterinary formulations in Hyderabad. Report

> Saltigo has passed a manufacturing audit by the U.S. FDA as it prepares to produce an active ingredient to supply the U.S. market. Report

> Piramal Healthcare has agreed to buy BioSyntech in a deal worth $3.8 million, gaining access to BioSyntech's proprietary biotherapeutic thermogel technology. Report

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.